trending Market Intelligence /marketintelligence/en/news-insights/trending/MogN1BE05RFtgAOuW6poag2 content esgSubNav
In This List

Lannett appoints CEO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Lannett appoints CEO

Lannett Co. Inc. appointed Timothy Crew as CEO, effective Jan. 2, 2018.

Arthur Bedrosian will continue to serve as CEO until Crew's appointment.

The board plans to appoint Crew as a director of the company after the completion of its 2018 annual shareholders meeting.

Crew joins Lannett from Cipla North America, where he served as CEO from 2013 to 2017. Before that he worked at Teva Pharmaceutical Industries Ltd.